Alayne P. Meyer , Sana Yousfi , Stefan Nicolau , Afrooz Rashnonejad , Jingting Zhu , Zarife Sahenk , Emma Frair , Hui Lin , Swetha Ramadesikan , Daniel Koboldt , Kevin M. Flanigan
{"title":"有其父必有其子:来自30岁肌肉活检的rna测序确定了ACTA1中一种新的剪接变体是弱线状肌病表型的原因","authors":"Alayne P. Meyer , Sana Yousfi , Stefan Nicolau , Afrooz Rashnonejad , Jingting Zhu , Zarife Sahenk , Emma Frair , Hui Lin , Swetha Ramadesikan , Daniel Koboldt , Kevin M. Flanigan","doi":"10.1016/j.nmd.2025.105416","DOIUrl":null,"url":null,"abstract":"<div><div><em>ACTA1</em>-related nemaline myopathy is a disorder typically presenting in the neonatal period, but later-onset cases have been described. The majority of patients carry <em>de novo</em> missense variants. We report a father and son with shared features of early-onset, but mild myopathic symptoms, including gross motor delay and facial weakness. Muscle biopsies showed nemaline rods. Genetic testing identified a novel splice variant in <em>ACTA1</em> (c.809–10C><em>A</em>). RNA-sequencing was performed on muscle, including the father’s sample which had been archived for 31 years; both showed retention of intron 5 in ∼20 % of transcripts, predicted to cause protein truncation, but not nonsense mediated decay. <em>In vitro</em> studies showed that the variant leads to the formation of ACTA1 aggregates. These findings provide functional support for the variant’s pathogenicity in dominantly inherited nemaline myopathy and rationale for the attenuated phenotype. This case highlights the utility of muscle biopsy and RNA-sequencing in the diagnosis of nemaline myopathy.</div></div>","PeriodicalId":19135,"journal":{"name":"Neuromuscular Disorders","volume":"52 ","pages":"Article 105416"},"PeriodicalIF":2.7000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Like father, like son: RNA-sequencing from a 30-year-old muscle biopsy identifies a novel splice variant in ACTA1 as the cause of an attenuated nemaline myopathy phenotype\",\"authors\":\"Alayne P. Meyer , Sana Yousfi , Stefan Nicolau , Afrooz Rashnonejad , Jingting Zhu , Zarife Sahenk , Emma Frair , Hui Lin , Swetha Ramadesikan , Daniel Koboldt , Kevin M. Flanigan\",\"doi\":\"10.1016/j.nmd.2025.105416\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><em>ACTA1</em>-related nemaline myopathy is a disorder typically presenting in the neonatal period, but later-onset cases have been described. The majority of patients carry <em>de novo</em> missense variants. We report a father and son with shared features of early-onset, but mild myopathic symptoms, including gross motor delay and facial weakness. Muscle biopsies showed nemaline rods. Genetic testing identified a novel splice variant in <em>ACTA1</em> (c.809–10C><em>A</em>). RNA-sequencing was performed on muscle, including the father’s sample which had been archived for 31 years; both showed retention of intron 5 in ∼20 % of transcripts, predicted to cause protein truncation, but not nonsense mediated decay. <em>In vitro</em> studies showed that the variant leads to the formation of ACTA1 aggregates. These findings provide functional support for the variant’s pathogenicity in dominantly inherited nemaline myopathy and rationale for the attenuated phenotype. This case highlights the utility of muscle biopsy and RNA-sequencing in the diagnosis of nemaline myopathy.</div></div>\",\"PeriodicalId\":19135,\"journal\":{\"name\":\"Neuromuscular Disorders\",\"volume\":\"52 \",\"pages\":\"Article 105416\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuromuscular Disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0960896625001439\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuromuscular Disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960896625001439","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Like father, like son: RNA-sequencing from a 30-year-old muscle biopsy identifies a novel splice variant in ACTA1 as the cause of an attenuated nemaline myopathy phenotype
ACTA1-related nemaline myopathy is a disorder typically presenting in the neonatal period, but later-onset cases have been described. The majority of patients carry de novo missense variants. We report a father and son with shared features of early-onset, but mild myopathic symptoms, including gross motor delay and facial weakness. Muscle biopsies showed nemaline rods. Genetic testing identified a novel splice variant in ACTA1 (c.809–10C>A). RNA-sequencing was performed on muscle, including the father’s sample which had been archived for 31 years; both showed retention of intron 5 in ∼20 % of transcripts, predicted to cause protein truncation, but not nonsense mediated decay. In vitro studies showed that the variant leads to the formation of ACTA1 aggregates. These findings provide functional support for the variant’s pathogenicity in dominantly inherited nemaline myopathy and rationale for the attenuated phenotype. This case highlights the utility of muscle biopsy and RNA-sequencing in the diagnosis of nemaline myopathy.
期刊介绍:
This international, multidisciplinary journal covers all aspects of neuromuscular disorders in childhood and adult life (including the muscular dystrophies, spinal muscular atrophies, hereditary neuropathies, congenital myopathies, myasthenias, myotonic syndromes, metabolic myopathies and inflammatory myopathies).
The Editors welcome original articles from all areas of the field:
• Clinical aspects, such as new clinical entities, case studies of interest, treatment, management and rehabilitation (including biomechanics, orthotic design and surgery).
• Basic scientific studies of relevance to the clinical syndromes, including advances in the fields of molecular biology and genetics.
• Studies of animal models relevant to the human diseases.
The journal is aimed at a wide range of clinicians, pathologists, associated paramedical professionals and clinical and basic scientists with an interest in the study of neuromuscular disorders.